BAP1 loss augments sensitivity to BET inhibitors in cancer cells.
Xu YY, Ren ZL, Liu XL, Zhang GM, Huang SS, Shi WH, Ye LX, Luo X, Liu SW, Li YL, Yu L.
Xu YY, et al.
Acta Pharmacol Sin. 2022 Jul;43(7):1803-1815. doi: 10.1038/s41401-021-00783-5. Epub 2021 Nov 4.
Acta Pharmacol Sin. 2022.
PMID: 34737422
Free PMC article.